Real-time enrollment status for this metastatic pancreatic ductal adenocarcinoma clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 9:59 AM UTC
| NCT Number | NCT06843551 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Pancreatic Ductal Adenocarcinoma |
| Phase | PHASE2 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Benjamin Spieler |
| Last Updated on CT.gov | August 21, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT06843551 is currently recruiting participants. This phase2 study for metastatic pancreatic ductal adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Benjamin Spieler. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06843551 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06843551 was last updated 1 week ago (August 21, 2026). HelloStudys verifies this status automatically.